Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Baxter
Deloitte
Mallinckrodt
US Army
Colorcon
Federal Trade Commission
Moodys
AstraZeneca

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087954

« Back to Dashboard

NDA 087954 describes VITAMIN K1, which is a drug marketed by Hospira and is included in three NDAs. It is available from three suppliers. Additional details are available on the VITAMIN K1 profile page.

The generic ingredient in VITAMIN K1 is phytonadione. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 087954
Tradename:VITAMIN K1
Applicant:Hospira
Ingredient:phytonadione
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 087954
Suppliers and Packaging for NDA: 087954
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VITAMIN K1 phytonadione INJECTABLE;INJECTION 087954 ANDA Hospira, Inc. 0409-9157 0409-9157-01 5 TRAY in 1 CONTAINER (0409-9157-01) > 5 AMPULE in 1 TRAY > .5 mL in 1 AMPULE
VITAMIN K1 phytonadione INJECTABLE;INJECTION 087954 ANDA Hospira, Inc. 0409-9157 0409-9157-25 5 TRAY in 1 CONTAINER (0409-9157-25) > 5 AMPULE in 1 TRAY > .5 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/0.5ML
Approval Date:Jul 25, 1983TE:BPRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Queensland Health
McKesson
Federal Trade Commission
Fuji
Merck
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot